{"id":66544,"date":"2023-07-26T13:40:18","date_gmt":"2023-07-26T08:10:18","guid":{"rendered":"http:\/\/finservwealth.com\/aurobindo-pharma-hits-52-week-high-on-fda-clean-chit-to-telangana-unit\/"},"modified":"2023-07-26T13:40:18","modified_gmt":"2023-07-26T08:10:18","slug":"aurobindo-pharma-hits-52-week-high-on-fda-clean-chit-to-telangana-unit","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/aurobindo-pharma-hits-52-week-high-on-fda-clean-chit-to-telangana-unit\/","title":{"rendered":"Aurobindo Pharma hits 52-week high on FDA clean chit to Telangana unit"},"content":{"rendered":"<p> The United States Food and Drug Administration (USFDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities<\/p><div id=\"finse-868820097\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/aurobindo-pharma-hits-52-week-highfda-clean-chit-to-telangana-unit_17132941.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The United States Food and Drug Administration (USFDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities The United States Food and Drug Administration (USFDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/aurobindo-pharma-hits-52-week-highfda-clean-chit-to-telangana-unit_17132941.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The United States Food and Drug Administration (USFDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/aurobindo-pharma-hits-52-week-highfda-clean-chit-to-telangana-unit_17132941.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The United States Food and Drug Administration (USFDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities The United States Food and Drug Administration (USFDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/aurobindo-pharma-hits-52-week-highfda-clean-chit-to-telangana-unit_17132941.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The United States Food and Drug Administration (USFDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-66544","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2021\/200x200\/a\/aurobindi-pharma_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/66544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=66544"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/66544\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=66544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=66544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=66544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}